The company had posted a net profit of Rs 28.75 crore for the corresponding period of the previous fiscal, Dr Lal PathLabs said in a filing to BSE.
Consolidated total income from operations rose to Rs 197.71 crore for the quarter under consideration as against Rs 171.84 crore for the year ago period.
Also Read
Consolidated total income from operations of the company stood at Rs 791.32 crore for the recently ended fiscal. It was Rs 659.59 crore for the previous fiscal year.
In a separate filing the company said its board has recommended a dividend of Rs 2.45 per equity share of Rs 10 each for the year ended March 31, 2016.
Shares of Dr Lal PathLabs today closed at Rs 949.50 per scrip on BSE, down 3.20 per cent from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)